Skip to content

Clinical trials

Hepatitis C, Chronic trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Country / region: New Zealand Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20072
20081
20091
20102
20116
20128
20132
20141
20152
20162
20172

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences10
Hoffmann-La Roche9
AbbVie2
Alios Biopharma Inc.2
Boehringer Ingelheim2
AbbVie (prior sponsor, Abbott)1
Antipodean Pharmaceuticals, Inc.1
Arrow Therapeutics1
Kirby Institute1
Presidio Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic32
Hepatitis C9

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.